Corbus Pharmaceuticals Presents Additional Data from RESOLVE-1 Study in Systemic Sclerosis

    NEXT STORY
    ALX Oncology Announces New Data from ASPEN-01, the Phase 1b Study of ALX148, Showing Promising Initial Clinical Responses in Patients with Advanced Solid Tumors
    PREV STORY
    Genocea Presents Positive GEN-009 Clinical Results, Update on GEN-011 Program and New InhibigenTM Mechanism of Action Data at Virtual SITC 2020
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Athenex, Inc. Announces Pricing of Offering of Common Stock

    BUFFALO, N.Y., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Athenex (Nasdaq:ATNX), a global biopharmaceutical company ...

    author_avatar
    NASDAQ Market News

    APAC In Vitro Diagnostics Market Worth $33.4 Billion By 2024: Grand View Research, Inc.

    San Francisco, Aug. 09, 2016 (GLOBE NEWSWIRE) -- The Asia Pacific In Vitro Diagnostics ...

    author_avatar
    NASDAQ Market News

    ABOG Appoints New Board of Directors Officer and Members, Division Chair, and Members of Subspecialty Divisions

    author_avatar
    NASDAQ Market News